Thomas C. Freyman is President & VP at ABBOTT LABORATORIES (ABT). They have made 6 open-market trades across 3 companies since 2006, most recently 2026-05-08.
CIK 0001239126
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $721K since 2013, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TEN | BUY | 2020-08-07 | 2020-08-07 | $7.70 | $231K | +0.2% | -4.3% | -13.0% |
| AGN | BUY | 2018-08-30 | 2018-09-04 | $190.69 | $210K | -1.0% | +0.9% | -16.9% |
| TEN | BUY | 2018-08-09 | 2018-08-10 | $44.49 | $222K | +1.8% | +6.3% | +6.0% |
| ABT | SELL · 10b5-1 | 2014-03-03 | 2014-03-04 | $39.10 | $117K | -8.3% | -2.3% | -2.3% |
| TEN | BUY | 2013-05-02 | 2013-05-03 | $38.26 | $57K | -28.5% | -2.9% | -2.9% |
| ABT | SELL · 10b5-1 | 2011-08-05 | 2011-08-09 | $49.19 | $974K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2011-05-09 | 2011-05-11 | $52.37 | $1.0M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2010-10-25 | 2010-10-27 | $52.94 | $1.2M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2010-07-26 | 2010-07-28 | $49.23 | $985K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2010-02-16 | 2010-02-18 | $53.92 | $113K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2010-02-01 | 2010-02-03 | $50.14 | $1.3M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2009-11-11 | 2009-11-13 | $53.50 | $1.1M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2009-02-17 | 2009-02-19 | $54.41 | $30K | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2007-01-29 | 2007-01-31 | $52.57 | $97K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2007-01-03 | 2007-01-05 | $49.04 | $3K | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2006-02-15 | 2006-02-16 | $43.85 | $34K | -8.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.